ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

Roche Markets CMV Test in Europe

April 29, 2011

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

House Approves 1.9 Percent Increase For NIH.

July 20, 2007

DCT Advisors Approve Recompetition Of Drug Discovery Groups

June 23, 1995